Carbinoxamine / dextromethorphan / phenylephrine Pregnancy and Breastfeeding Warnings
Brand names: DMax, DMax Pediatric, DMax Pediatric Drops, DMax Syrup, Dacex-A, TriTuss-A Drops, Trituss-A, X-Hist DM, XiraHistDM
Carbinoxamine / dextromethorphan / phenylephrine Pregnancy Warnings
Carbinoxamine/dextromethorphan/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbinoxamine/dextromethorphan/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
Carbinoxamine / dextromethorphan / phenylephrine Breastfeeding Warnings
There are no data on the excretion of carbinoxamine/dextromethorphan/phenylephrine into human milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2004) "Product Information. Trituss-A Drops (carbinoxamine/dextromethorphan/phenylephrine)." Everett Laboratories Inc
- (2005) "Product Information. Dacex-A (carbinoxamine/dextromethorphan/phenylephrine)." Cypress Pharmaceutical Inc (a division of Currax Pharmaceuticals)
References for breastfeeding information
- (2004) "Product Information. Trituss-A Drops (carbinoxamine/dextromethorphan/phenylephrine)." Everett Laboratories Inc
- (2005) "Product Information. Dacex-A (carbinoxamine/dextromethorphan/phenylephrine)." Cypress Pharmaceutical Inc (a division of Currax Pharmaceuticals)
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.